Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 16, 2017
Heart-type fatty acid-binding protein in cardiovascular disease: A systemic reviewYoichiro Otaki, Tetsu Watanabe, Isao Kubota
International Journal of Molecular Sciences|July 2, 2021
The Role of HECT-Type E3 Ligase in the Development of Cardiac DiseaseJun Goto, Yoichiro Otaki, Tetsu Watanabe, et al.
International Journal of Molecular Sciences|November 13, 2025
Ubiquitin E3 Ligases and p53 in Doxorubicin-Induced CardiotoxicityShingo Tachibana, Yoichiro Otaki, Jun Goto, et al.
JACC. Case Reports|August 1, 2025
Tailored Endovascular Therapy for Deformed VIABAHN VBX Balloon-Expandable Stent Graft by External Force in Aortoiliac DiseaseTaku Shikama, Yoichiro Otaki, Tetsu Watanabe, et al.
Internal Medicine (Tokyo, Japan)|August 6, 2025
Anemia of Renal Tubular Damage and Mortality in the General Population: The Yamagata (Takahata) studyYoichiro Otaki, Tetsu Watanabe, Shigehiko Kato, et al.
International Journal of Cardiology|July 9, 2016
Renal tubular damage is associated with poor clinical outcome in patients with peripheral artery disease who underwent endovascular therapyYoichiro Otaki, Tetsu Watanabe, Hiroki Takahashi, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|April 20, 2026
The Drug-Coated Balloon and Primary Patency in Endovascular Therapy for Femoropopliteal Lesions With "Black Rock" Nodular CalcificationTaku Shikama, Yoichiro Otaki, Daisuke Kinoshita, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 11, 2015
Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patientsYoichiro Otaki, Hiroki Takahashi, Tetsu Watanabe, et al.
Pageof 12